Conferences Blogs
10|22|25
Pharma’s Next Wave: Precision, Trust and Transformation Insights from DHC Disrupt Summit
At this year’s Digital Healthcare Coalition (DHC) Disrupt Summit, pharma’s most forward-thinking marketers explored how technology and innovation are reshaping engagement across the healthcare ecosystem. Faruk Capan, CEO of EVERSANA INTOUCH and Chief Innovation Officer at EVERSANA, joined industry peers, Corrine Lynberg (Novo Nordisk), Eric McCulley (UCB Pharma), and Mark Bard, Co-Founder of The DHC […]
10|07|25
Looking Ahead to Dreamforce 2025
Every year, Dreamforce brings together leaders, innovators, and partners across industries to explore the future of Salesforce technology. This year feels especially pivotal for the Life Sciences sector, as new technologies and strategies are reshaping how pharma and biotech organizations work, connect, and deliver impact. Our team is proud to represent EVERSANA INTOUCH at Dreamforce […]
07|10|25
Cannes 2025: How CMOs Define The Future of Work and What’s to Come
Each year, the Cannes Lions International Festival of Creativity brings together the world’s most visionary marketers—and 2025 was no exception. Among the attendees was Angela Tenuta, Global Group President at EVERSANA INTOUCH, who shared her reflections in a recent PharmaLive article after joining peers from around the world to explore the evolving role of marketing leadership.
07|02|25
The Omnichannel Advantage: Insights from Dan Gandor at the DHC Roundtable
Discover how EVERSANA INTOUCH’s Dan Gandor is redefining omnichannel strategy in pharma. Key takeaways from the DHC Roundtable at Amgen reveal scalable innovations from rare disease marketing.
07|01|25
Cannes 2025: Lessons in Branding, AI and the Rise of Creator Content
In his PharmaLive article, John Kenny explores how brands have shifted from speculating about AI to integrating it into creative workflows. From collapsing production timelines to evolving influencer content, discover how AI is reshaping pharma marketing.
06|24|25
Cannes 2025: Pharma’s Creative Inflection Point
In her latest PharmaLive article, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, reflects on three key themes from this year’s Cannes Lions Festival of Creativity—each signaling a new era for pharmaceutical marketing.
06|13|25
AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era
At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]
06|10|25
AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025
At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care.
09|27|24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Every year, ESMO brings together experts from pharma, research and advocacy organizations, and HCPs to hear about the year’s biggest oncology breakthroughs. This year’s theme was “Shaping the Future of Anticancer Therapies.”
07|08|24
Lessons from Lions: EVERSANA INTOUCH Takes on Cannes
In this POV, we delve into the insights we gathered from Cannes 2024, exploring the practicalities of creativity, the intelligent use of artificial intelligence, and the importance of cultural changemaking.